WuXi AppTec

WuXi AppTec is a global Contract Research, Development, and Manufacturing Organization (CRDMO) that provides an integrated, open-access platform for the pharmaceutical and life sciences industries. The company offers end-to-end services spanning drug discovery, development, and manufacturing. Its capabilities include chemistry services, biology discovery, preclinical and clinical testing, and advanced therapies, all supported by a global network of operations across Asia, Europe, and North America. By combining scientific rigor with operational scale, the company aims to help partners research, develop, and produce innovative healthcare products more efficiently.

The company serves more than 6,000 customers worldwide, including biotech and pharmaceutical companies and research institutions, to accelerate the path from scientific discovery to patient treatment. By operating as a collaborative partner, WuXi AppTec lowers research and development barriers and provides essential infrastructure, such as specialized discovery platforms, regulatory-compliant manufacturing, and testing services. Its work supports diverse therapeutic modalities, helping innovators deliver treatments across numerous disease areas and contributing to a global healthcare ecosystem where breakthroughs are made more accessible.